Skip to NavigationSkip to content


Pfizer to build $465m sterile injectable plant in Michigan

Pfizer has unveiled plans to invest $465 million to build a new sterile injectables plant in Portage, Michigan, saying that the facility will create 450 jobs and “strengthen Pfizer’s capability to produce and supply critical, life-saving injectable medicines for patients around the world”.

Pfizer seeks tax breaks in return for planned $456m facility

Pfizer has submitted proposals to officials in Portage, Michigan, for a major expansion of its manufacturing site in the city.

The planned expansion would cost $456 million to complete and, according to Pfizer, would create 140 new jobs within two years, with a further 450 jobs being added within six years. The project would see a two-story, 400,000-square-foot sterile processing facility be created.

Albemarle expands API capacity at Michigan facility

Fine chemicals, polymers and catalysts specialist Albemarle has brought new manufacturing capacity for active pharmaceutical ingredients (APIs) online at its facility in Michigan, US, to meet "increasing demand for both generic API products and custom manufacturing services".

The expansion of the South Haven plant is part of a series of initiatives at Albemarle which are intended to double the size of its business by 2015 to more than $5 billion.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches